US Patent

US10927258 — Process for the preparation of Indigotindisulfonate sodium (indigo carmine)

Composition of Matter · Assigned to Biophore India Pharmaceuticals Pvt Ltd · Expires 2037-12-23 · 12y remaining

Vulnerability score 12/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects an improved method for preparing highly or substantially pure Indigotindisulfonate sodium, also known as indigo carmine.

USPTO Abstract

This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation.

Drugs covered by this patent

indigotindisulfonate-sodium (INDIGOTINDISULFONATE SODIUM)

Patent Metadata

Patent number: US10927258
Jurisdiction: US
Classification: Composition of Matter
Expires: 2037-12-23
Drug substance claim: Yes
Drug product claim: No
Assignee: Biophore India Pharmaceuticals Pvt Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.